-
1
-
-
79953107054
-
Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan
-
Aziz H, Gil ML, Waheed Y, Adeeb U, Raza A, Bilal I, Athar MA (2011) Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan. Infect Genet Evol 11: 640-645.
-
(2011)
Infect Genet Evol
, vol.11
, pp. 640-645
-
-
Aziz, H.1
Gil, M.L.2
Waheed, Y.3
Adeeb, U.4
Raza, A.5
Bilal, I.6
Athar, M.A.7
-
2
-
-
0028806153
-
Chronic hepatitis. An update on terminology and reporting
-
Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19: 1409-1417.
-
(1995)
Am J Surg Pathol
, vol.19
, pp. 1409-1417
-
-
Batts, K.P.1
Ludwig, J.2
-
3
-
-
33646250428
-
The natural history of hepatitis C virus (HCV) infection
-
Chen SL, Morgan TR (2006) The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3: 47-52.
-
(2006)
Int J Med Sci
, vol.3
, pp. 47-52
-
-
Chen, S.L.1
Morgan, T.R.2
-
4
-
-
3342892905
-
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIVcoinfected persons
-
Aids Clinical Trials Group A5071 Study Team
-
Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team (2004) Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIVcoinfected persons. N Engl J Med 29: 451-459.
-
(2004)
N Engl J Med
, vol.29
, pp. 451-459
-
-
Chung, R.T.1
Andersen, J.2
Volberding, P.3
Robbins, G.K.4
Liu, T.5
Sherman, K.E.6
Peters, M.G.7
Koziel, M.J.8
Bhan, A.K.9
Alston, B.10
Colquhoun, D.11
Nevin, T.12
Harb, G.13
van der Horst, C.14
-
5
-
-
80054897004
-
The role of insulin resistance in HIV/hepatitis C virus-coinfected patients
-
Eslam M, López-Cortés LF, Romero-Gomez M (2011) The role of insulin resistance in HIV/hepatitis C virus-coinfected patients. Curr Opin HIV AIDS 6: 553-558.
-
(2011)
Curr Opin HIV AIDS
, vol.6
, pp. 553-558
-
-
Eslam, M.1
López-Cortés, L.F.2
Romero-Gomez, M.3
-
6
-
-
4444278724
-
Treatment of chronic hepatitis C infection with peginterferons plus ribavirin
-
Fried M, Hadziyannis S (2004) Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Semin Liver Dis 24: 47-54.
-
(2004)
Semin Liver Dis
, vol.24
, pp. 47-54
-
-
Fried, M.1
Hadziyannis, S.2
-
7
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 26: 975-982.
-
(2002)
N Engl J Med
, vol.26
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Gonçales Jr., F.L.6
Häussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
8
-
-
84855975685
-
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
-
Gonvers JJ, Heim MH, Cavassini M, Müllhaupt B, Genné D, Bernasconi E, Borovicka J, Cerny A, Chave JP, Chuard C, Dufour F, Dutoit V, Malinverni R, Monnat M, Negro F, Troilliet N, Oneta C (2010) Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Medical Weekly 14: 1-19.
-
(2010)
Swiss Medical Weekly
, vol.14
, pp. 1-19
-
-
Gonvers, J.J.1
Heim, M.H.2
Cavassini, M.3
Müllhaupt, B.4
Genné, D.5
Bernasconi, E.6
Borovicka, J.7
Cerny, A.8
Chave, J.P.9
Chuard, C.10
Dufour, F.11
Dutoit, V.12
Malinverni, R.13
Monnat, M.14
Negro, F.15
Troilliet, N.16
Oneta, C.17
-
9
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
-
(2009)
Nature
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
Urban, T.J.6
Heinzen, E.L.7
Qiu, P.8
Bertelsen, A.H.9
Muir, A.J.10
Sulkowski, M.11
McHutchison, J.G.12
Goldstein, D.B.13
-
10
-
-
1542378867
-
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
-
Pegasys International Study Group
-
Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group (2004) Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2: 346-355.
-
(2004)
Ann Intern Med
, vol.2
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr., H.2
Morgan, T.R.3
Balan, V.4
Diago, M.5
Marcellin, P.6
Ramadori, G.7
Bodenheimer Jr., H.8
Bernstein, D.9
Rizzetto, M.10
Zeuzem, S.11
Pockros, P.J.12
Lin, A.13
Ackrill, A.M.14
-
11
-
-
62149105964
-
A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
-
Idrees M, Riazuddin S (2009) A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients. BMC Gastroenterol 20: 5.
-
(2009)
BMC Gastroenterol
, vol.20
, pp. 5
-
-
Idrees, M.1
Riazuddin, S.2
-
12
-
-
79951675730
-
Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b
-
Kawaoka T, Hayes CN, Ohishi W, Ochi H, Maekawa T, Abe H, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Kubo M, Tsunoda T, Nakamura Y, Kumada H, Chayama K (2011) Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b. J Hepatol 54: 408-414.
-
(2011)
J Hepatol
, vol.54
, pp. 408-414
-
-
Kawaoka, T.1
Hayes, C.N.2
Ohishi, W.3
Ochi, H.4
Maekawa, T.5
Abe, H.6
Tsuge, M.7
Mitsui, F.8
Hiraga, N.9
Imamura, M.10
Takahashi, S.11
Kubo, M.12
Tsunoda, T.13
Nakamura, Y.14
Kumada, H.15
Chayama, K.16
-
13
-
-
34047262154
-
Viral hepatitis in HIV infection
-
Koziel M, Peters M (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445-1454.
-
(2007)
N Engl J Med
, vol.356
, pp. 1445-1454
-
-
Koziel, M.1
Peters, M.2
-
14
-
-
0035811625
-
Hepatitis C virus infection
-
Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
-
(2001)
N Engl J Med
, vol.345
, pp. 41-52
-
-
Lauer, G.M.1
Walker, B.D.2
-
15
-
-
77952693487
-
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
-
McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, Tillmann HL, Muir AJ, McHutchison JG (2010) Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 138: 2307-2314.
-
(2010)
Gastroenterology
, vol.138
, pp. 2307-2314
-
-
McCarthy, J.J.1
Li, J.H.2
Thompson, A.3
Suchindran, S.4
Lao, X.Q.5
Patel, K.6
Tillmann, H.L.7
Muir, A.J.8
McHutchison, J.G.9
-
16
-
-
84925580987
-
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response
-
Mangia A, Thompson AJ, Santoro R, Piazzolla V, Tillmann HL, Patel K, Shianna KV, Mottola L, Petruzzellis D, Bacca D, Carretta V, Minerva N, Goldstein DB, McHutchison JG (2010) An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response. Gastroenterology 139: 821-827.
-
(2010)
Gastroenterology
, vol.139
, pp. 821-827
-
-
Mangia, A.1
Thompson, A.J.2
Santoro, R.3
Piazzolla, V.4
Tillmann, H.L.5
Patel, K.6
Shianna, K.V.7
Mottola, L.8
Petruzzellis, D.9
Bacca, D.10
Carretta, V.11
Minerva, N.12
Goldstein, D.B.13
McHutchison, J.G.14
-
17
-
-
1642465363
-
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy
-
Myers RP, Benhamou Y, Bochet M, Thibault V, Mehri D, Poynard T (2004) Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy. AIDS 18: 75-79.
-
(2004)
AIDS
, vol.18
, pp. 75-79
-
-
Myers, R.P.1
Benhamou, Y.2
Bochet, M.3
Thibault, V.4
Mehri, D.5
Poynard, T.6
-
19
-
-
77957825574
-
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus
-
Pineda JA, Caruz A, Rivero A, Neukam K, Salas I, Camacho A, Palomares JC, Mira JA, Martínez A, Roldán C, de la Torre J, Macías J (2010) Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 1: 788-795.
-
(2010)
Clin Infect Dis
, vol.1
, pp. 788-795
-
-
Pineda, J.A.1
Caruz, A.2
Rivero, A.3
Neukam, K.4
Salas, I.5
Camacho, A.6
Palomares, J.C.7
Mira, J.A.8
Martínez, A.9
Roldán, C.10
de la Torre, J.11
Macías, J.12
-
20
-
-
80555127355
-
Drugs in development for chronic hepatitis C: a promising future
-
Pockros PJ (2011) Drugs in development for chronic hepatitis C: a promising future. Expert Opin Biol Ther 11: 1611-1622.
-
(2011)
Expert Opin Biol Ther
, vol.11
, pp. 1611-1622
-
-
Pockros, P.J.1
-
21
-
-
85027955533
-
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
-
Rallón NI, Soriano V, Naggie S, Restrepo C, Goldstein D, Vispo E Thompson A, McHutchison J, Soriano V (2011) IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin. AIDS 15: 1025-1033.
-
(2011)
AIDS
, vol.15
, pp. 1025-1033
-
-
Rallón, N.I.1
Soriano, V.2
Naggie, S.3
Restrepo, C.4
Goldstein, D.5
Vispo, E.6
Thompson, A.7
McHutchison, J.8
Soriano, V.9
-
22
-
-
77949831342
-
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
-
Swiss Hepatitis C Cohort Study; Swiss HIV Cohort Study
-
Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Müllhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY; Swiss Hepatitis C Cohort Study; Swiss HIV Cohort Study (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138: 1338-1345.
-
(2010)
Gastroenterology
, vol.138
, pp. 1338-1345
-
-
Rauch, A.1
Kutalik, Z.2
Descombes, P.3
Cai, T.4
Di Iulio, J.5
Mueller, T.6
Bochud, M.7
Battegay, M.8
Bernasconi, E.9
Borovicka, J.10
Colombo, S.11
Cerny, A.12
Dufour, J.F.13
Furrer, H.14
Günthard, H.F.15
Heim, M.16
Hirschel, B.17
Malinverni, R.18
Moradpour, D.19
Müllhaupt, B.20
Witteck, A.21
Beckmann, J.S.22
Berg, T.23
Bergmann, S.24
Negro, F.25
Telenti, A.26
Bochud, P.Y.27
more..
-
23
-
-
70349242026
-
Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients
-
Reddy KR, Messinger D, Popescu M, Hadziyannis SJ (2009) Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients. J Viral. Hepatol 16: 724-731.
-
(2009)
J Viral. Hepatol
, vol.16
, pp. 724-731
-
-
Reddy, K.R.1
Messinger, D.2
Popescu, M.3
Hadziyannis, S.J.4
-
24
-
-
79951679619
-
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
-
Sarrazin C, Susser S, Doehring A, Lange CM, Müller T, Schlecker C, Herrmann E, Lötsch J, Berg T (2011) Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J Hepatol 2: 415-421.
-
(2011)
J Hepatol
, vol.2
, pp. 415-421
-
-
Sarrazin, C.1
Susser, S.2
Doehring, A.3
Lange, C.M.4
Müller, T.5
Schlecker, C.6
Herrmann, E.7
Lötsch, J.8
Berg, T.9
-
25
-
-
70349548852
-
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
-
Suppiah V, Moldovan M, Ahlenstiel G Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
-
(2009)
Nat Genet
, vol.41
, pp. 1100-1104
-
-
Suppiah, V.1
Moldovan, M.2
Ahlenstiel, G.3
Weltman, M.4
Abate, M.L.5
Bassendine, M.6
Spengler, U.7
Dore, G.J.8
Powell, E.9
Riordan, S.10
Sheridan, D.11
Smedile, A.12
Fragomeli, V.13
Müller, T.14
Bahlo, M.15
Stewart, G.J.16
Booth, D.R.17
George, J.18
-
26
-
-
70349533037
-
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
-
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
-
(2009)
Nat Genet
, vol.41
, pp. 1105-1109
-
-
Tanaka, Y.1
Nishida, N.2
Sugiyama, M.3
Kurosaki, M.4
Matsuura, K.5
Sakamoto, N.6
Nakagawa, M.7
Korenaga, M.8
Hino, K.9
Hige, S.10
Ito, Y.11
Mita, E.12
Tanaka, E.13
Mochida, S.14
Murawaki, Y.15
Honda, M.16
Sakai, A.17
Hiasa, Y.18
Nishiguchi, S.19
Koike, A.20
Sakaida, I.21
Imamura, M.22
Ito, K.23
Yano, K.24
Masaki, N.25
Sugauchi, F.26
Izumi, N.27
Tokunaga, K.28
Mizokami, M.29
more..
-
27
-
-
84873715787
-
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
-
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 8: 780-798.
-
(2009)
Nature
, vol.8
, pp. 780-798
-
-
Thomas, D.L.1
Thio, C.L.2
Martin, M.P.3
Qi, Y.4
Ge, D.5
O'Huigin, C.6
Kidd, J.7
Kidd, K.8
Khakoo, S.I.9
Alexander, G.10
Goedert, J.J.11
Kirk, G.D.12
Donfield, S.M.13
Rosen, H.R.14
Tobler, L.H.15
Busch, M.P.16
McHutchison, J.G.17
Goldstein, D.B.18
Carrington, M.19
-
28
-
-
3343012408
-
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
-
Apricot Study Group
-
Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group (2004) Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 29: 438-450.
-
(2004)
N Engl J Med
, vol.29
, pp. 438-450
-
-
Torriani, F.J.1
Rodriguez-Torres, M.2
Rockstroh, J.K.3
Lissen, E.4
Gonzalez-García, J.5
Lazzarin, A.6
Carosi, G.7
Sasadeusz, J.8
Katlama, C.9
Montaner, J.10
Sette Jr., H.11
Passe, S.12
De Pamphilis, J.13
Duff, F.14
Schrenk, U.M.15
Dieterich, D.T.16
|